192 related articles for article (PubMed ID: 32128860)
1. On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited.
Putter H; Schumacher M; van Houwelingen HC
Biom J; 2020 May; 62(3):790-807. PubMed ID: 32128860
[TBL] [Abstract][Full Text] [Related]
2. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
Geskus RB
Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
[TBL] [Abstract][Full Text] [Related]
3. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
Austin PC; Steyerberg EW; Putter H
Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.
Austin PC; Putter H; Lee DS; Steyerberg EW
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008368. PubMed ID: 35098725
[TBL] [Abstract][Full Text] [Related]
5. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
Austin PC; Fine JP
Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
[TBL] [Abstract][Full Text] [Related]
6. A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.
Austin PC; Latouche A; Fine JP
Stat Med; 2020 Jan; 39(2):103-113. PubMed ID: 31660633
[TBL] [Abstract][Full Text] [Related]
7. Competing risks regression for stratified data.
Zhou B; Latouche A; Rocha V; Fine J
Biometrics; 2011 Jun; 67(2):661-70. PubMed ID: 21155744
[TBL] [Abstract][Full Text] [Related]
8. The importance of censoring in competing risks analysis of the subdistribution hazard.
Donoghoe MW; Gebski V
BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
[TBL] [Abstract][Full Text] [Related]
9. Analysis and design of randomised clinical trials involving competing risks endpoints.
Tai BC; Wee J; Machin D
Trials; 2011 May; 12():127. PubMed ID: 21595883
[TBL] [Abstract][Full Text] [Related]
10. Sample size calculations in the presence of competing risks.
Latouche A; Porcher R
Stat Med; 2007 Dec; 26(30):5370-80. PubMed ID: 17955563
[TBL] [Abstract][Full Text] [Related]
11. Subdistribution hazard models for competing risks in discrete time.
Berger M; Schmid M; Welchowski T; Schmitz-Valckenberg S; Beyersmann J
Biostatistics; 2020 Jul; 21(3):449-466. PubMed ID: 30418529
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis in the presence of competing risks.
Zhang Z
Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
[TBL] [Abstract][Full Text] [Related]
13. Weighted NPMLE for the Subdistribution of a Competing Risk.
Bellach A; Kosorok MR; Rüschendorf L; Fine JP
J Am Stat Assoc; 2019; 114(525):259-270. PubMed ID: 31073256
[TBL] [Abstract][Full Text] [Related]
14. A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.
He P; Eriksson F; Scheike TH; Zhang MJ
Scand Stat Theory Appl; 2016 Mar; 43(1):103-122. PubMed ID: 27034534
[TBL] [Abstract][Full Text] [Related]
15. Semiparametric competing risks regression under interval censoring using the R package intccr.
Park J; Bakoyannis G; Yiannoutsos CT
Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
[TBL] [Abstract][Full Text] [Related]
16. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
Nolan EK; Chen HY
Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
[TBL] [Abstract][Full Text] [Related]
18. Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes.
Poguntke I; Schumacher M; Beyersmann J; Wolkewitz M
BMC Med Res Methodol; 2018 Jul; 18(1):79. PubMed ID: 30012114
[TBL] [Abstract][Full Text] [Related]
19. Flexible competing risks regression modeling and goodness-of-fit.
Scheike TH; Zhang MJ
Lifetime Data Anal; 2008 Dec; 14(4):464-83. PubMed ID: 18752067
[TBL] [Abstract][Full Text] [Related]
20. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
Katsahian S; Resche-Rigon M; Chevret S; Porcher R
Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
